B. Riley Wealth Management’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$373 Sell
1,851
-233
-11% -$49.7K ﹤0.01% 478
2022
Q1
$472K Sell
2,084
-5
-0.2% -$1.18K 0.04% 338
2021
Q4
$564K Buy
2,089
+232
+12% +$57.4K 0.04% 318
2021
Q3
$449K Buy
1,857
+14
+0.8% +$3.53K 0.03% 364
2021
Q2
$437K Sell
1,843
-31
-2% -$7.06K 0.05% 257
2021
Q1
$411K Sell
1,874
-58
-3% -$11.6K 0.05% 248
2020
Q4
$338K Sell
1,932
-204
-10% -$35.2K 0.04% 255
2020
Q3
$345K Buy
2,136
+192
+10% +$30.4K 0.04% 282
2020
Q2
$278K Buy
+1,944
New +$269K 0.03% 316
2015
Q1
Sell
-84
Closed -$7K 1069
2014
Q4
$7K Hold
84
0.01% 803
2014
Q3
$7K Hold
84
0.01% 855
2014
Q2
$7K Hold
84
﹤0.01% 895
2014
Q1
$7K Buy
+84
New +$6.7K 0.01% 836

Other funds holding LH

B. Riley Wealth Management's LH Position: Q2 2022 in Review

B. Riley Wealth Management reduced its Labcorp (LH) stake by 11% in Q2 2022, selling an estimated $49.7K and leaving 1,851 shares worth $373. The position accounts for ﹤0.01% of the portfolio, ranked #478.

B. Riley Wealth Management first reported a position in LH in Q1 2014 and has held it in 13 quarters since. The position peaked at $564K in Q4 2021. 966 funds tracked by Wall St. Rank hold LH as of Q2 2022.

  • B. Riley Wealth Management held 1,851 shares of Labcorp worth $373 as of Q2 2022.
  • B. Riley Wealth Management sold 233 Labcorp shares in Q2 2022, an estimated $49.7K.
  • Labcorp made up ﹤0.01% of B. Riley Wealth Management's portfolio in Q2 2022, its #478 holding.
  • B. Riley Wealth Management first reported a position in Labcorp in Q1 2014 and has held it in 13 quarters since.
  • B. Riley Wealth Management's Labcorp position peaked at $564K in Q4 2021.
  • 966 funds tracked by Wall St. Rank held Labcorp as of Q2 2022.

Based on B. Riley Wealth Management's 13F filing for Q2 2022, filed 9 Sep 2022.